Literature DB >> 19997983

An antireflux anastomosis following esophagectomy: a randomized controlled trial.

Ahmad Aly1, Glyn G Jamieson, David I Watson, Peter G Devitt, Roger Ackroyd, Chris J Stoddard.   

Abstract

BACKGROUND: Reflux of duodeno-gastric fluid is a significant problem after esophagectomy with gastric conduit reconstruction. Symptoms may be severe and impact considerably upon the quality of life. Previous studies have suggested that a fundoplication type anastomosis may limit post-esophagectomy reflux. AIM: The purpose of this study was to determine whether a modified fundoplication at the gastro-esophageal anastomosis prevents reflux after esophagectomy.
METHODS: Prospective multicenter randomized controlled trial to compare a conventional end of esophagus to side of gastric conduit anastomosis with a modified fundoplication anastomosis in patients undergoing esophagectomy with intrathoracic anastomosis. Major outcomes were reflux symptoms, symptoms of dysphagia, and complications.
RESULTS: Fifty-six patients were enrolled. The fundoplication anastomosis was associated with significantly lower incidence of reflux (40% vs 70%), as well as a reduced incidence of severe reflux (8% vs 30%). Disturbance of sleep due to reflux was significantly reduced in the fundoplication group (18% vs 47%) as was the incidence of respiratory symptoms. The fundoplication anastomosis was not associated with an increase in dysphagia, and there was no difference in complications between the two groups.
CONCLUSIONS: Fundoplication anastomosis during esophagectomy is effective in protecting patients from reflux symptoms after esophagectomy and improves quality of life, particularly with regard to sleep disturbance.

Entities:  

Mesh:

Year:  2009        PMID: 19997983     DOI: 10.1007/s11605-009-1107-0

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  25 in total

Review 1.  Gastroplasty: yes or no to gastric drainage procedure.

Authors:  T Lerut; W Coosemans; P De Leyn; D Van Raemdonck
Journal:  Dis Esophagus       Date:  2001       Impact factor: 3.429

Review 2.  Long-term outcomes following esophagectomy.

Authors:  J A Schuetz
Journal:  Chest Surg Clin N Am       Date:  2000-08

3.  Reconstruction of the cardia and fundus of the stomach.

Authors:  G WOOLER
Journal:  Thorax       Date:  1956-12       Impact factor: 9.139

4.  A long-term follow-up of patients resected for benign esophageal stricture using the Inkwell esophagogastrostomy.

Authors:  P Wara; M J Oster; P Funch-Jensen; J Andresen; P Ottosen
Journal:  Ann Surg       Date:  1979-08       Impact factor: 12.969

5.  Anti-reflux palliative resections for inoperable carcinoma of the esophagogastric junction.

Authors:  W C Butterfield
Journal:  J Thorac Cardiovasc Surg       Date:  1971-09       Impact factor: 5.209

6.  A physical model of the intrathoracic stomach.

Authors:  W A Bemelman; J Verburg; W H Brummelkamp; P J Klopper
Journal:  Am J Physiol       Date:  1988-02

7.  A new dysphagia score with objective validation.

Authors:  M Dakkak; J R Bennett
Journal:  J Clin Gastroenterol       Date:  1992-03       Impact factor: 3.062

8.  Control of postresection gastroesophageal reflux: the intercostal pedicle esophagogastropexy experience of 26 years.

Authors:  N J Demos; V A Kulkarni; A Port; J Micale
Journal:  Am Surg       Date:  1993-03       Impact factor: 0.688

9.  Antireflux anastomosis following oesophagectomy.

Authors:  A Aly; G G Jamieson; M Pyragius; P G Devitt
Journal:  ANZ J Surg       Date:  2004-06       Impact factor: 1.872

10.  Esophagogastrostomy. Analysis of 55 cases.

Authors:  A D Boyd; R Cukingnan; R M Engelman; S A Localio; L Slattery; D A Tice; J A Bardin; F C Spencer
Journal:  J Thorac Cardiovasc Surg       Date:  1975-11       Impact factor: 5.209

View more
  8 in total

1.  Clinical application of mucosal valve technique for anastomosis during esophagogastrostomy.

Authors:  Bin Li; Yu-Min Li; Jian-Hua Zhang; Yun-Feng Su; Cheng Wang; Zhi-Qiang Wang; Yun-Jiu Gou; Tie-Niu Song; Jian-Bao Yang
Journal:  J Gastrointest Surg       Date:  2013-10-18       Impact factor: 3.452

2.  A Novel Technique of Anti-reflux Esophagogastrostomy Following Left Thoracoabdominal Esophagectomy for Carcinoma of the Esophagogastric Junction.

Authors:  Shinji Mine; Souya Nunobe; Masayuki Watanabe
Journal:  World J Surg       Date:  2015-09       Impact factor: 3.352

3.  [Monocarboxylate transporter 1 enhances the sensitivity of breast cancer cells to 3-bromopyruvate in vitro].

Authors:  Qi-Xiang Li; Pei Zhang; Fang Liu; Xian-Zhi Wang; Lu Li; Zhong-Kun Wang; Chen-Chen Jiang; Hai-Lun Zheng; Hao Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-05-20

4.  Barrett's esophagus after resection of the gastroesophageal junction: effects of concomitant fundoplication.

Authors:  Athanasios Tsiouris; Zane Hammoud; Vic Velanovich
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

5.  Hand-sewn versus stapled anastomoses for esophagectomy: We will probably never know which is better.

Authors:  Tommi Järvinen; Jonathan Cools-Lartigue; Eric Robinson; Jari Räsänen; Ilkka Ilonen
Journal:  JTCVS Open       Date:  2021-07-28

6.  Embedded cervical esophagogastrostomy: a simple and convenient method using a circular stapler after esophagectomy for esophageal carcinomas.

Authors:  Sen Wu; Mingyao Chen; Li Wei; Zhong Chen
Journal:  Ann Surg Oncol       Date:  2013-05-05       Impact factor: 5.344

7.  Sleep disturbances and quality of life in postoperative management after esophagectomy for esophageal cancer.

Authors:  Marco Scarpa; Eleonora Pinto; Luca M Saadeh; Matteo Parotto; Anna Da Roit; Elisa Pizzolato; Rita Alfieri; Matteo Cagol; Elisabetta Saraceni; Fabio Baratto; Carlo Castoro
Journal:  World J Surg Oncol       Date:  2014-05-21       Impact factor: 2.754

8.  Prevalence and risk factors of reflux after esophagectomy for esophageal cancer.

Authors:  Samina Park; Chang Hyun Kang; Hyun Joo Lee; In Kyu Park; Young Tae Kim
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 3.005

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.